Skip Navigation

This Article
Right arrow Print PDF (5846K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Rhim, H.
Right arrow Articles by Rice, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhim, H.
Right arrow Articles by Rice, A. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1994, Vol. 22, No. 21 4405-4413
© 1994

RNA

Exon2 of HIV-2 Tat Contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA

Hyanghsuk Rhim and Andrew P. Rice*

Division of Molecular Virology, Baylor College of Medicine One Baylor Plaza, Houston, TX77030, USA

*To whom correspondence should be addressed

Received July 22, 1994. Revised September 18, 1994. Accepted September 18, 1994.

Human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) express related Tat proteins that are encoded in two exons. Tat proteins bind directly to the TAR RNA element contained in the 5' ends of viral transcripts and thereby stimulate transcription through an as yet unidentified mechanism. We have investigated the functional significance of exon2 of the HIV-2 Tat protein by examining properties of proteins consisting of exoni alone or exon1+2. In transactivation assays in vivo, exon2 modestly increased HIV-2 Tat stimulation of transcription from the HIV-2 long terminal repeat (LTR) but had no effect on transcription from the HIV-1 LTR. In HeLa cells, exon2 increased transactivation of the HIV-2 LTR by approximately three-fold, while in COS and Jurkat cells this value was less than two-fold. In binding assays in vitro, exon2 increased the binding affinity of the HIV-2 Tat protein to HIV-2 TAR RNA. Results with GAL4 fusion proteins and a synthetic promoter containing GAL4 DNA binding sites indicated that exon2 does not contribute to the HIV-2 Tat activation domain. These observations suggest that exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing the binding affinity to HIV-2 TAR RNA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
S. M. Foskett, R. Ghose, D. N. Tang, D. E. Lewis, and A. P. Rice
Antiapoptotic Function of Cdk9 (TAK/P-TEFb) in U937 Promonocytic Cells
J. Virol., February 1, 2001; 75(3): 1220 - 1228.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
N. F. Marshall, G. K. Dahmus, and M. E. Dahmus
Regulation of Carboxyl-terminal Domain Phosphatase by HIV-1 Tat Protein
J. Biol. Chem., November 27, 1998; 273(48): 31726 - 31730.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. O. Gold, X. Yang, C. H. Herrmann, and A. P. Rice
PITALRE, the Catalytic Subunit of TAK, Is Required for Human Immunodeficiency Virus Tat Transactivation In Vivo
J. Virol., May 1, 1998; 72(5): 4448 - 4453.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.